Relaxo Footwears Approves ESOP Cancellation and Fresh Grant Under Phase-V
Relaxo Footwears Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 11:20 pm
Relaxo Footwears Approves ESOP Cancellation and Fresh Grant Under Phase-V Relaxo Footwears' Nomination and Remuneration Committee approved the cancellation of 27,600 stock options under Phase-V of the RFL ESOP Plan 2014 on 13th Nov'26 following an employee's resignation. The cancelled options were returned to the pool for future grants. Concurrently, the committee approved a fresh grant of 14,700 options to eligible employees, convertible into equity shares of Re. 1 face value each. The exercise price will reflect the latest closing price on the exchange with highest trading volume prior to the meeting.
Original exchange filing (PDF)
More announcements from Relaxo Footwears Ltd
- Link for Audio Recording 路 16 Nov 2026
- Investor Presentation 路 13 Nov 2026
- Press Release 路 13 Nov 2026
- Setting up of a footwear manufacturing facility in kenya through a joint venture 路 13 Nov 2026
- Financial results for quarter and half year ended September 30, 2026 路 13 Nov 2026
- Outcome of Board Meeting for Approval of Unaudited Financial Results for the quarter and half ended September 30, 2026. 路 13 Nov 2026
- Investor Conference Call 路 16 Nov 2026
- RELAXO FOOTWEARS LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
